| Filed On | Filing |
|---|---|
| 15 Oct 2026 |
Form 4: Carson Michael A, Group President, Medicare&Spec
Gave up 7,130 shares to cover exercise price or tax ($500K) |
| 08 Oct 2026 |
8-K: Other Events
On October 8, 2026, Centene Corporation (the Company) delivered a notice of redemption to redeem on October 23, 2026 (the redemption date) all of the remaining $568,664,000 aggregate principal amount of its outstanding 4.25% Notes due De... |
| 30 Sep 2026 |
Form 4: Tyler Lauren M, Director
Received 482 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Tanji Kenneth, Director
Received 603 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Samuels Theodore R. Ii, Director
Received 583 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Eppinger Frederick H, Director
Received 864 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Coughlin Christopher J, Director
Received 583 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Pienkos Theodore J, Corporate Controller & CAO
Gave up 1,092 shares to cover exercise price or tax ($75.8K) |
| 16 Sep 2026 |
8-K: Regulation FD Disclosure
Centene Corporation (the Company) will be participating at the Deutsche Bank 2026 Healthcare Summit on Wednesday, September 16, 2026, at 9:00 a.m. EDT. During the conference, and in subsequent discussions with investors continuing throug... |
| 27 Aug 2026 |
Form 4: Koster Christopher, Secretary & General Counsel
Sold 56,500 shares ($3.78M) |
| 26 Aug 2026 | 144 |
| 26 Aug 2026 | 144 |
| 19 Aug 2026 |
Form 4: Koster Christopher, Secretary & General Counsel
Sold 47,603 shares ($3.11M) |
| 18 Aug 2026 | 144 |
| 17 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 05 Aug 2026 | 144 |
| 29 Jul 2026 | 8-K: Other Events |
| 28 Jul 2026 |
Form 4: Diaz Paul J, Director
Received 2,771 shares as a grant or award |
| 28 Jul 2026 |
Form 3: Diaz Paul J, Director
Holds 0 shares of No Securities Beneficially Owned |
| 28 Jul 2026 | 10-Q |
Loading...
